MXC mgc pharmaceuticals ltd

HL pharma licence, page-2

  1. 1,447 Posts.
    lightbulb Created with Sketch.  104
    I would guess that it is:
    A. because cannepil is not ready to sell and as such hasn't undergone any necessary testing
    and
    B. that HL pharma is required to get all approvals etc an it can't because of A
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.